(PRAP) Amundi Index Solutions - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2089239276

Exchange-Traded Funds, Corporate Bonds

Description: PRAP Amundi Index Solutions

Amundi Index Solutions Amundi Prime US Corporates UCITS ETF DR (C) is an exchange-traded fund (ETF) listed on XETRA, tracking the Morningstar US Corp Bd TR USD index. This ETF provides investors with exposure to a diversified portfolio of US corporate bonds, aiming to replicate the performance of the underlying index.

The fund is designed to offer a cost-effective and transparent way to invest in the US corporate bond market. By tracking the Morningstar US Corp Bd TR USD index, the ETF provides access to a broad range of investment-grade corporate bonds issued by US companies. The funds investment objective is to deliver returns that are in line with the underlying index, making it a suitable option for investors seeking to gain exposure to the US corporate bond market.

Analyzing the available , we observe that the ETFs last price is 18.27, with a 20-day simple moving average (SMA) of 17.97 and a 50-day SMA of 18.38, indicating a potential bullish trend. The 200-day SMA stands at 18.87, suggesting a longer-term downtrend. The average true range (ATR) is 0.21, representing a 1.13% daily volatility. The 52-week high and low are 19.74 and 17.41, respectively, indicating the ETFs price range over the past year.

Combining the with , we note that the funds assets under management (AUM) stand at 85.94M EUR. Considering the current market conditions and the ETFs technical indicators, we can forecast that the ETFs price may continue to fluctuate within a narrow range. The bullish trend indicated by the 20-day SMA and the relatively low ATR suggest a potential for a short-term price increase. However, the longer-term downtrend indicated by the 200-day SMA may cap the upside potential. Therefore, a forecast for the ETFs price could be a gradual increase towards 19.00, with potential resistance at 19.50.

To capitalize on this forecast, investors may consider accumulating the ETF on dips towards the 20-day SMA or lower, with a target price of 19.00 and a stop-loss below the 52-week low of 17.41. It is essential to continuously monitor the ETFs price action and adjust the investment strategy accordingly.

Additional Sources for PRAP ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

PRAP ETF Overview

Market Cap in USD 101m
Category USD Corporate Bond
TER 0.07%
IPO / Inception 2019-09-10

PRAP ETF Ratings

Growth Rating -7.37
Fundamental -
Dividend Rating 0.0
Rel. Strength -0.59
Analysts -
Fair Price Momentum 16.38 EUR
Fair Price DCF -

PRAP Dividends

Currently no dividends paid

PRAP Growth Ratios

Growth Correlation 3m -19.9%
Growth Correlation 12m -22.2%
Growth Correlation 5y 8.7%
CAGR 5y -0.80%
CAGR/Max DD 5y -0.05
Sharpe Ratio 12m 0.09
Alpha -6.77
Beta -0.040
Volatility 83.87%
Current Volume 3.6k
Average Volume 20d 2.5k
What is the price of PRAP shares?
As of July 07, 2025, the stock is trading at EUR 17.72 with a total of 3,632 shares traded.
Over the past week, the price has changed by +0.08%, over one month by -1.08%, over three months by -4.43% and over the past year by -2.81%.
Is Amundi Index Solutions a good stock to buy?
Neither. Based on ValueRay´s Analyses, Amundi Index Solutions is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -7.37 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PRAP is around 16.38 EUR . This means that PRAP is currently overvalued and has a potential downside of -7.56%.
Is PRAP a buy, sell or hold?
Amundi Index Solutions has no consensus analysts rating.
What are the forecasts for PRAP share price target?
According to our own proprietary Forecast Model, PRAP Amundi Index Solutions will be worth about 17.7 in July 2026. The stock is currently trading at 17.72. This means that the stock has a potential downside of -0.17%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 17.7 -0.2%